Human-growth hormone injection-related Creutzfeldt-Jakob Disease (Q92020)

From determinar.ia.br - Determine suas informações
Revision as of 07:10, 16 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
Human growth hormone-related Creutzfeldt-Jakob Disease (CJD) is CJD in patients treated with human growth hormone derived from the pituitary glands in the brains of cadaveric donors. The clinical features include progressive cerebellar ataxia and a longer disease course than classical sCJD. After the prohibition of the cadaveric use for growth hormone, the occurrence of CJD in this manner has been drastically reduced.
Language Label Description Also known as
default for all languages
ID_866329807
    English
    Human-growth hormone injection-related Creutzfeldt-Jakob Disease
    Human growth hormone-related Creutzfeldt-Jakob Disease (CJD) is CJD in patients treated with human growth hormone derived from the pituitary glands in the brains of cadaveric donors. The clinical features include progressive cerebellar ataxia and a longer disease course than classical sCJD. After the prohibition of the cadaveric use for growth hormone, the occurrence of CJD in this manner has been drastically reduced.

      Statements

      CID11:ID_866329807
      0 references
      dki-india-ID_866329807
      0 references
      Concluído
      0 references